Brandywine Global Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-218,649	Closed	-$23.9M	–	779
2023 Q1	$23.9M	Sell	218,649 -310,344	-59%	-$34.3M	0.19%	132
2022 Q4	$60.2M	Sell	528,993 -144,930	-22%	-$12M	0.47%	57
2022 Q3	$41.7M	Buy	+673,923	New	+$47.1M	0.39%	74
2020 Q3	–	Sell	-79	Closed	-$5K	–	793
2020 Q2	$5K	Sell	79 -37,146	-100%	-$1.59M	﹤0.01%	717
2020 Q1	$1.1M	Sell	37,225 -927,602	-96%	-$31.4M	0.01%	510
2019 Q4	$34.9M	Sell	964,827 -119,125	-11%	-$3.65M	0.25%	96
2019 Q3	$29.5M	Buy	1,083,952 +973,669	+883%	+$25.2M	0.22%	104
2019 Q2	$2.65M	Sell	110,283 -1,063,265	-91%	-$27M	0.02%	507
2019 Q1	$31M	Sell	1,173,548 -313,599	-21%	-$7.43M	0.21%	100
2018 Q4	$29.1M	Sell	1,487,147 -991,051	-40%	-$19.4M	0.22%	107
2018 Q3	$48.5M	Sell	2,478,198 -444,512	-15%	-$8.45M	0.3%	81
2018 Q2	$48.4M	Sell	2,922,710 -824,097	-22%	-$12.6M	0.31%	85
2018 Q1	$53.2M	Sell	3,746,807 -413,667	-10%	-$6.11M	0.34%	75
2017 Q4	$60.7M	Buy	4,160,474 +149,854	+4%	+$2.1M	0.36%	70
2017 Q3	$50.9M	Buy	4,010,620 +51,818	+1%	+$659K	0.32%	74
2017 Q2	$47M	Buy	3,958,802 +428,546	+12%	+$5.33M	0.3%	79
2017 Q1	$52.2M	Buy	3,530,256 +1,038,483	+42%	+$16.8M	0.33%	72
2016 Q4	$40.3M	Sell	2,491,773 -152,985	-6%	-$2.77M	0.26%	90
2016 Q3	$48M	Sell	2,644,758 -164,624	-6%	-$3.22M	0.32%	82
2016 Q2	$46.3M	Buy	2,809,382 +340,618	+14%	+$5.51M	0.31%	82
2016 Q1	$40.9M	Buy	2,468,764 +198,244	+9%	+$3.47M	0.27%	87
2015 Q4	$49.2M	Buy	+2,270,520	New	+$44.2M	0.31%	80